Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity

INTRODUCTION: Trastuzumab has been used in the treatment of human epidermal growth factor receptor 2 (HER2)-expressing breast cancer, but its efficacy is limited by de novo or acquired resistance. Although many mechanisms have been proposed to explain resistance to trastuzumab, little is known conce...

Descripción completa

Detalles Bibliográficos
Autores principales: Duong, Minh Ngoc, Cleret, Aurore, Matera, Eva-Laure, Chettab, Kamel, Mathé, Doriane, Valsesia-Wittmann, Sandrine, Clémenceau, Béatrice, Dumontet, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482271/
https://www.ncbi.nlm.nih.gov/pubmed/25908175
http://dx.doi.org/10.1186/s13058-015-0569-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482271/
https://www.ncbi.nlm.nih.gov/pubmed/25908175
http://dx.doi.org/10.1186/s13058-015-0569-0

Ejemplares similares